Successful treatment of diffuse pulmonary lymphangiomatosis with bevacizumab

Ann Intern Med. 2012 Jun 5;156(11):839-40. doi: 10.7326/0003-4819-156-11-201206050-00016.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Female
  • Humans
  • Lung Diseases / congenital*
  • Lung Diseases / drug therapy
  • Lymphangiectasis / congenital*
  • Lymphangiectasis / drug therapy
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab

Supplementary concepts

  • Lymphangiectasia, pulmonary, congenital